Gynecological infectious disease virus antibody detection method
Through intelligent sterile sample collection system, intelligent ultrasonic equipment and nano-antibody capture technology, combined with multifunctional detection instruments, the complexity and accuracy of traditional gynecological infectious disease virus detection methods are solved, and efficient, accurate and safe detection is achieved As a result, it provides a powerful tool for the early diagnosis and treatment of gynecological infectious diseases.
Patent Information
- Application Number
- CN202411177614.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Traditional gynecological infectious disease virus antibody detection methods are complex in operation, long detection time, low accuracy and specificity, single sample pretreatment methods, difficult to fully release virus particles and easily destroy the antibody structure, and the detection instrument has a single function, making it difficult to meet the different viruses. The best testing requirements and the judgment criteria are not personalized enough, which affects the accuracy of the testing results.
Adopt an intelligent sterile sample collection system, combining intelligent ultrasonic equipment and nano-antibody capture technology, and integrate multiple advanced detection technologies using multi-function detection instruments. Intelligent algorithms automatically adjust detection parameters, use encryption technology to ensure data security, and set personalization. Determination criteria, testing for different viruses.
Improve the accuracy, specificity and speed of detection, ensure the reliability and safety of detection results, reduce the impact of external pollution, shorten the detection time, provide personalized judgment standards, and enhance the safety of detection data. and privacy protection.
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of gynecological disease monitoring, and specifically relates to a method for detecting antibodies to gynecological infectious disease viruses. Background Art
[0002] In today's society, the prevention and treatment of gynecological infectious diseases has always been an important issue in the field of public health. Common gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV) and molluscum virus (MCV) pose a serious threat to women's health. Accurate and rapid detection of these viral antibodies is crucial for the early diagnosis, treatment and prevention of the disease. Traditional methods for detecting antibodies to gynecological infectious diseases have many limitations, such as complex operation, long detection time, low accuracy and specificity. During sample collection, external contamination may be introduced due to lax aseptic operation, affecting the test results. The sample pretreatment method is relatively single, making it difficult to fully release viral particles while ensuring that the antibody structure is not destroyed. The performance of antibody capture reagents needs to be improved, and the screening and optimization of specific antibodies are not accurate enough, resulting in limited accuracy and specificity of the test. In terms of detection instruments, traditional instruments often have single functions, insufficient sensitivity and specificity, and are difficult to meet the optimal detection requirements of different viruses. In addition, the judgment criteria for different viruses are not personalized enough, affecting the accuracy of the test results.
[0003] With the continuous advancement of science and technology, medical testing technology is also constantly developing. The emergence of new materials, biotechnology and intelligent equipment has provided possibilities for the innovation of virus antibody detection methods for gynecological infectious diseases. The application of nanotechnology has brought new breakthroughs in antibody capture reagents. Ultrafine nanomagnetic beads and specially engineered nanoantibodies can bind to viral antibodies more efficiently. The development of intelligent ultrasonic equipment has made sample pretreatment more accurate and can automatically optimize ultrasonic processing parameters according to different viral characteristics. The new generation of multifunctional detection instruments integrates a variety of advanced detection technologies and has intelligent algorithms that can automatically adjust detection parameters, thereby improving the sensitivity, specificity and rapidity of detection. At the same time, the development of information security technology also provides a guarantee for the security of detection data. Against this background, it is of great practical significance to develop an innovative virus antibody detection method for gynecological infectious diseases to improve the accuracy, specificity, rapidity and safety of detection. Summary of the invention
[0004] The purpose of the present invention is to provide a method for detecting antibodies to gynecological infectious diseases viruses to solve the problems raised in the above-mentioned background technology.
[0005] To achieve the above object, the present invention provides the following technical solution: a method for detecting antibodies to gynecological infectious diseases viruses, comprising the following steps:
[0006] Step 1: Use an intelligent sterile gynecological sample collection system to collect cervical secretions, vaginal secretions, or selectively collect urine, blood and other auxiliary samples according to specific circumstances. The collection process is equipped with a real-time monitoring device to ensure aseptic operation standards, and detect common gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV), and molluscum virus MCV;
[0007] Step 2: Place the collected sample in a multifunctional buffer composed of a high-efficiency phosphate buffer, a new environmentally friendly surfactant and a strong stabilizer, stir it gently with a precisely controlled stirring device, and use an intelligent ultrasonic device for ultrasonic treatment. Suppose the virus type is V, and the virus characteristic parameter set is C(V) = {c 1 , c 2 , …, c n}, where c represents different virus characteristic parameters, such as virus particle size, hardness, structural stability, etc., the ultrasonic frequency is f = F(C(V)), and the processing time is t = T(C(V)), where F and T are functional relationships fitted by experimental data and machine learning algorithms. The ultrasonic processing parameters can be automatically optimized according to different virus characteristics. During the operation of the algorithm, the Advanced Encryption Standard (AES) is used to encrypt the virus characteristic parameters and the calculation process. The Secure Sockets Layer (SSL) protocol is used during data transmission and storage to ensure data security and confidentiality and prevent unauthorized access and tampering. At the same time, strict access control is set, and only authorized personnel can access algorithm-related data and operation processes;
[0008] Step 3: Use the antibody capture reagent based on nano-antibody capture technology, which is composed of ultra-fine nano-magnetic beads and specially engineered nano-antibodies. Mix the pre-treated sample with the antibody capture reagent in an intelligent temperature-controlled incubation device. The incubation temperature range is 36-44°C and the time is 32-58 minutes to ensure that the viral antibodies in the sample are efficiently combined with the nano-antibodies on the magnetic beads. For different viruses, the nano-antibodies have been strictly screened and optimized, and have extremely high specificity and affinity for viral antigens, covering the key areas of surface proteins and internal proteins of gynecological infectious disease viruses;
[0009] Step 4: Use a new generation of multifunctional detection instruments, which integrate multiple detection technologies such as fluorescent immunoassay, enzyme-linked immunosorbent assay, chemiluminescent immunoassay and quantum dot immunoassay. It has an intelligent algorithm that can automatically adjust the detection parameters according to different viruses. The built-in quality monitoring system monitors the instrument performance and the reliability of the test results in real time. It has a strong data processing capability to quickly analyze the test signal and accurately determine the virus antibody content in the sample. It also supports remote control and data transmission functions. In the process of data transmission and storage, multiple encryption technologies are used, including a combination of symmetric encryption and asymmetric encryption, to encrypt the test data, and digital certificates are used for identity authentication to ensure that the identities of both parties in the data transmission are authentic and reliable. In addition, the software system of the detection instrument is regularly updated and scanned for vulnerabilities to prevent potential security risks;
[0010] Step 5: Based on the results of the detection instrument, combined with the precise judgment criteria set based on big data analysis and artificial intelligence algorithms, determine whether the patient is infected with gynecological infectious viruses, and set personalized and dynamically adjusted judgment criteria for different viruses.
[0011] Preferably, the concentration of the phosphate buffer in the multifunctional buffer can be adjusted within the range of 0.02-0.09 mol / L, the concentration of the new environmentally friendly surfactant is 0.02%-0.09%, and the concentration of the strong stabilizer is 0.2%-0.9%. For different viruses, the specific composition and concentration of the buffer can be automatically adjusted by the intelligent system.
[0012] Preferably, the nanoantibodies in the antibody capture reagent are specially engineered single-domain antibodies, which target viral antigens covering key regions of surface proteins and internal proteins of gynecological infectious disease viruses, have high specificity and affinity for different viruses, and are screened by an intelligent screening system.
[0013] Preferably, the incubation conditions of the intelligent temperature-controlled incubation device can be automatically set and optimized according to different viruses.
[0014] Preferably, the new generation of multifunctional detection instrument has ultra-high sensitivity, specificity and rapid detection capabilities, can automatically select and adjust detection methods and parameters according to different viruses, realize remote control and data transmission, and facilitate medical institutions to conduct remote consultation and quality control. At the same time, the instrument strictly abides by information security specifications during operation to ensure the security and privacy protection of detection data.
[0015] Compared with the prior art, the present invention has the following beneficial effects:
[0016] In terms of accuracy, the intelligent sterile gynecological sample collection system ensures that the collection process strictly follows the sterile operation specifications, reducing the impact of external contamination on the test results. The intelligent ultrasonic equipment automatically optimizes the ultrasonic processing parameters according to the characteristics of different viruses, which can fully release the virus particles without destroying the antibody structure. The specially engineered nano-antibodies and the carefully screened and optimized specific antibodies have greatly improved the accuracy and specificity of the test. The new generation of multifunctional detection instruments integrates a variety of advanced detection technologies, and the intelligent algorithm automatically adjusts the detection parameters. Combined with personalized judgment criteria, it further ensures the accuracy of the test results. Secondly, in terms of rapidity, intelligent equipment and optimized detection processes have greatly shortened the detection time. The intelligent sample collection, efficient sample pretreatment, rapid antibody capture and multifunctional detectors The high-speed data processing capability of the device makes the entire detection process more efficient, and can provide patients with diagnostic results in a timely manner, thus buying precious time for the early treatment of the disease. Furthermore, in terms of security, encryption technology is used to encrypt the virus characteristic parameters and calculation process, and multiple encryption and security authentication mechanisms are used in the data transmission and storage process to ensure the integrity and security of the detection data, prevent unauthorized access and tampering, and protect the privacy of patients. Finally, from the perspective of practical significance, the innovative detection method of this case provides a powerful tool for the prevention and treatment of gynecological infectious diseases. Accurate and rapid detection helps in early diagnosis and treatment, reduces the risk of disease transmission, and improves women's health level. At the same time, it also provides new ideas and directions for the development of medical detection technology and promotes progress in the field of public health. DETAILED DESCRIPTION
[0017] The technical solutions in the embodiments of the present invention will be described clearly and completely below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0018] The present invention provides a method for detecting antibodies to gynecological infectious diseases viruses, comprising the following steps:
[0019] Step 1: Use an intelligent sterile gynecological sample collection system to collect cervical secretions, vaginal secretions, or selectively collect urine, blood and other auxiliary samples according to specific circumstances. The collection process is equipped with a real-time monitoring device to ensure aseptic operation standards, and detect common gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV), and molluscum virus MCV;
[0020] Step 2: Place the collected sample in a multifunctional buffer composed of a high-efficiency phosphate buffer, a new environmentally friendly surfactant and a strong stabilizer, stir it gently with a precisely controlled stirring device, and use an intelligent ultrasonic device for ultrasonic treatment. Suppose the virus type is V, and the virus characteristic parameter set is C(V) = {c 1 , c 2 , …, c n}, where c i Represents different virus characteristic parameters, such as virus particle size, hardness, structural stability, etc. The ultrasonic frequency is f=F(C(V)), and the processing time is t=T(C(V)), where F and T are functional relationships fitted by experimental data and machine learning algorithms. The ultrasonic processing parameters can be automatically optimized according to different virus characteristics. During the operation of the algorithm, the Advanced Encryption Standard (AES) is used to encrypt the virus characteristic parameters and the calculation process. The Secure Sockets Layer (SSL) protocol is used during data transmission and storage to ensure data security and confidentiality and prevent unauthorized access and tampering. At the same time, strict access control is set, and only authorized personnel can access algorithm-related data and operation processes;
[0021] Step 3: Use the antibody capture reagent based on nano-antibody capture technology, which is composed of ultra-fine nano-magnetic beads and specially engineered nano-antibodies. Mix the pre-treated sample with the antibody capture reagent in an intelligent temperature-controlled incubation device. The incubation temperature range is 36-44°C and the time is 32-58 minutes to ensure that the viral antibodies in the sample are efficiently combined with the nano-antibodies on the magnetic beads. For different viruses, the nano-antibodies have been strictly screened and optimized, and have extremely high specificity and affinity for viral antigens, covering the key areas of surface proteins and internal proteins of gynecological infectious disease viruses;
[0022] Step 4: Use a new generation of multifunctional detection instruments, which integrate multiple detection technologies such as fluorescent immunoassay, enzyme-linked immunosorbent assay, chemiluminescent immunoassay and quantum dot immunoassay. It has an intelligent algorithm that can automatically adjust the detection parameters according to different viruses. The built-in quality monitoring system monitors the instrument performance and the reliability of the test results in real time. It has a strong data processing capability to quickly analyze the test signal and accurately determine the virus antibody content in the sample. It also supports remote control and data transmission functions. In the process of data transmission and storage, multiple encryption technologies are used, including a combination of symmetric encryption and asymmetric encryption, to encrypt the test data, and digital certificates are used for identity authentication to ensure that the identities of both parties in the data transmission are authentic and reliable. In addition, the software system of the detection instrument is regularly updated and scanned for vulnerabilities to prevent potential security risks;
[0023] Step 5: Based on the results of the detection instrument, combined with the precise judgment criteria set based on big data analysis and artificial intelligence algorithms, determine whether the patient is infected with gynecological infectious viruses, and set personalized and dynamically adjusted judgment criteria for different viruses.
[0024] Furthermore, in terms of accuracy, the intelligent sterile sample collection system strictly follows the sterile operation specifications to reduce the impact of external contamination on the test results from the source. The intelligent ultrasonic equipment automatically optimizes the ultrasonic processing parameters according to the characteristics of different viruses, fully considering the characteristic parameters such as virus particle size, hardness, and structural stability, and determines the ultrasonic frequency and processing time through functional relationships, which can not only fully release the virus particles, but also ensure the integrity of the antibody structure, laying the foundation for the accuracy of subsequent tests. The application of nano-antibody capture technology enables the specially engineered nano-antibodies to be combined with ultra-fine nano-magnetic beads, which have extremely high specificity and affinity for viral antigens, thereby improving the accuracy and specificity of the test. The new generation of multifunctional detection instruments integrates a variety of advanced detection technologies, and the intelligent algorithm automatically adjusts the detection parameters, combined with personalized judgment criteria, to further ensure the accuracy of the test results. In terms of rapidity, the entire detection process is intelligent. It is intelligent and efficient. From sample collection to detection and analysis, each link cooperates with each other, which greatly shortens the detection time. The intelligent sample collection, efficient sample pretreatment, rapid antibody capture and high-speed data processing capabilities of the multifunctional detection instrument enable patients to obtain diagnosis results in time, and gain precious time for early treatment of the disease. In terms of security, the application of encryption technology encrypts the virus characteristic parameters and calculation process. The multiple encryption and security authentication mechanisms in the data transmission and storage process effectively protect the integrity and security of the detection data, prevent unauthorized access and tampering, and fully protect the privacy of patients. From a practical point of view, the present invention provides a powerful tool for the prevention and treatment of gynecological infectious diseases, helps early diagnosis and treatment, reduces the risk of disease transmission, and improves the health level of women. At the same time, it also provides a new direction for the development of medical detection technology and promotes progress in the field of public health.
[0025] The formula algorithm establishes a functional relationship between the virus characteristic parameters and the ultrasonic treatment parameters, and uses experimental data and machine learning algorithms for fitting. This means that for different viruses, the system can automatically calculate the most suitable ultrasonic frequency and treatment time based on their specific characteristic parameters. For example, for viruses with larger and harder virus particles, a higher ultrasonic frequency and a longer treatment time may be required to fully release the virus particles; for viruses with poor structural stability, a lower ultrasonic frequency and a shorter treatment time are required to avoid destroying the antibody structure. This personalized parameter optimization method improves the effect of sample pretreatment and provides better quality samples for subsequent detection steps, thereby further improving the accuracy and reliability of the entire detection method.
[0026] In this embodiment, the concentration of the phosphate buffer in the multifunctional buffer can be adjusted within the range of 0.02-0.09 mol / L, the concentration of the new environmentally friendly surfactant is 0.02%-0.09%, and the concentration of the strong stabilizer is 0.2%-0.9%. For different viruses, the specific composition and concentration of the buffer can be automatically adjusted by the intelligent system.
[0027] Furthermore, for different viruses, the specific composition and concentration of the buffer can be automatically adjusted by the intelligent system, which greatly improves the adaptability and accuracy of the detection method. In the detection of gynecological infectious disease viruses, different viruses have different characteristics and require a specific buffer environment to achieve the best detection effect. For example, for human papillomavirus (HPV), the appropriate phosphate buffer concentration, surfactant and stabilizer ratio can ensure that during the sample pretreatment process, the virus particles are fully released without destroying the antibody structure. By intelligently adjusting the buffer composition, it is possible to accurately create an environment that is conducive to the release of virus particles and can protect the stability of antibodies based on the characteristics of HPV, thereby improving the accuracy of the detection. For herpes simplex virus (HSV) and molluscum contagiosum virus The same is true for other viruses such as MCV. The buffer composition is automatically adjusted according to their respective characteristics to meet the personalized needs of different virus detection. At the same time, the use of new environmentally friendly surfactants and strong stabilizers not only improves the performance of the buffer, but also reduces the impact on the environment. In practical applications, this automatically adjustable buffer system greatly improves the detection efficiency, reduces repeated detection due to inappropriate buffer, saves time and cost, and the precise buffer concentration range ensures the reliability and stability of the test results, providing a strong basis for doctors to accurately diagnose gynecological infectious diseases, helping to detect diseases early and treat them in time, thereby improving women's health and making important contributions to the prevention and treatment of gynecological infectious diseases in the field of public health.
[0028] In this embodiment, the nanoantibodies in the antibody capture reagent are specially engineered single-domain antibodies that target viral antigens covering key regions of surface proteins and internal proteins of gynecological infectious virus. They have high specificity and affinity for different viruses and are screened by an intelligent screening system.
[0029] Furthermore, in terms of accuracy, nano-antibody capture technology has greatly improved detection accuracy. The antibody capture reagent composed of ultrafine nano-magnetic beads and specially engineered nano-antibodies can bind to viral antibodies more efficiently. Nano-antibodies have been strictly screened and optimized, and have extremely high specificity and affinity for antigens of different viruses. They can accurately identify the surface proteins and key internal protein areas of gynecological infectious disease viruses, greatly reducing the occurrence of false positive and false negative results. Compared with traditional antibody capture reagents, its performance is more outstanding, laying a solid foundation for accurate diagnosis. In terms of rapidity, this new antibody capture reagent can complete the antibody capture process in a shorter time. Ultrafine nano-magnetic beads can quickly adsorb viral antibodies, combined with an intelligent temperature-controlled incubation device for incubation within a specific temperature and time range, which greatly shortens the detection time. In clinical practice, rapid detection can provide patients with diagnostic results in a timely manner, gaining precious opportunities for early treatment of the disease. It saves precious time and helps improve the success rate of treatment and the quality of life of patients. In terms of safety, nano-antibody capture technology also provides a guarantee for the security of test data. Nano-antibodies that have undergone special engineering modifications have higher stability and are not easily interfered by external factors during sample processing and testing, reducing the risk of data errors caused by unstable reagents. At the same time, it cooperates more closely with the new generation of multifunctional testing instruments to ensure the integrity and security of test data, prevent unauthorized access and tampering, and protect the privacy of patients. From a practical perspective, nano-antibody capture technology provides a powerful tool for the prevention and treatment of gynecological infectious diseases. Its high accuracy, rapidity and safety contribute to the early detection and diagnosis of gynecological infectious diseases, reduce the risk of disease transmission, and improve women's health. At the same time, it has set a new benchmark for the development of medical testing technology, promoted technological progress in related fields, and provided new ideas and methods for future medical testing.
[0030] In this embodiment, the incubation conditions of the intelligent temperature-controlled incubation device can be automatically set and optimized according to different viruses.
[0031] Furthermore, in terms of accuracy, the device can automatically set and optimize incubation conditions according to different viruses to ensure efficient binding of viral antibodies in the sample with nanoantibodies on the magnetic beads. Different gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV) and molluscum virus MCV have different characteristics, and the required incubation temperature and time are also different. By intelligently adjusting the incubation conditions, the specificity and accuracy of antibody binding can be maximized, and false positive or false negative results caused by improper incubation conditions can be reduced, providing a strong guarantee for the accurate diagnosis of the disease. Secondly, in terms of efficiency, automatic setting and optimization of incubation conditions greatly shortens the detection time. Traditional incubation devices often require manual setting of parameters and cannot be accurately adjusted for different viruses, resulting in a cumbersome and time-consuming detection process. The intelligent temperature-controlled incubation device can quickly determine the optimal incubation conditions according to the virus type, making the entire detection process more efficient, which is beneficial to It is crucial for patients who urgently need diagnostic results. It can provide doctors with accurate diagnostic basis in time and buy precious time for early treatment of the disease. Furthermore, in terms of flexibility, the device adapts to the needs of multiple virus detection. With the continuous deepening of medical research, new gynecological infectious disease viruses may continue to emerge. The automatic adjustment function of the intelligent temperature-controlled incubation device enables it to easily cope with the detection needs of different viruses without the need for large-scale equipment updates and modifications, saving costs and time for laboratories and medical institutions. Finally, from the perspective of the overall detection method, the intelligent temperature-controlled incubation device cooperates with other intelligent equipment and technologies to form an efficient, accurate and safe gynecological infectious disease virus antibody detection system. Its existence makes the entire detection process more intelligent and automated, improves the overall level of detection, and provides strong technical support for the prevention and treatment of gynecological infectious diseases, which helps to reduce the risk of disease transmission and improve women's health.
[0032] In this embodiment, the new generation of multifunctional detection instrument has ultra-high sensitivity, specificity and rapid detection capabilities. It can automatically select and adjust detection methods and parameters according to different viruses, realize remote control and data transmission, and facilitate medical institutions to conduct remote consultation and quality control. At the same time, the instrument strictly abides by information security specifications during operation to ensure the security and privacy protection of detection data.
[0033] Furthermore, in terms of improving accuracy, big data analysis can integrate a large amount of test data and clinical information to provide a more comprehensive basis for the setting of judgment criteria. Artificial intelligence algorithms can perform intelligent analysis based on the characteristics of different viruses and various complex factors to make the judgment criteria more accurate. Personalized judgment criteria can be set for different viruses, taking into full consideration the characteristics of common gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV) and molluscum virus (MCV), avoiding inaccurate judgments based on generalizations. Dynamically adjusted judgment criteria can be continuously optimized with new research results and actual test conditions to ensure that the test results always maintain high accuracy and are based on actual results. From an application perspective, this precise judgment standard can provide doctors with a more reliable basis for diagnosis. In the early diagnosis of the disease, accurately judging whether the patient is infected with the virus is crucial for taking timely treatment measures. Personalized judgment standards can reduce the risk of misdiagnosis and missed diagnosis, allowing patients to receive more appropriate treatment plans. At the same time, in the field of public health, accurate test results can help to timely discover the epidemic trends of infectious diseases, take effective prevention and control measures, reduce the risk of disease transmission, and protect the health of women. In addition, this innovative judgment method has also set a new benchmark for the development of medical testing technology, promoted the continuous progress of the entire industry, and provided more possibilities for future disease diagnosis and prevention.
[0034] The working principle and use process of the present invention:
[0035] First, in the sample collection stage, the intelligent sterile gynecological sample collection system plays a key role. The system is equipped with a real-time monitoring device, and the operators strictly follow the specifications to ensure that the collection process fully meets the sterile requirements. Whether it is cervical secretions, vaginal secretions, or auxiliary samples such as urine and blood collected according to specific circumstances, it can minimize the impact of external contamination on the test results. The collected samples are tested for common gynecological infectious diseases such as human papillomavirus (HPV), herpes simplex virus (HSV), and molluscum virus MCV, laying the foundation for subsequent accurate diagnosis. Then, enter the sample pre-treatment In the processing stage, the collected samples are placed in a multifunctional buffer and gently stirred by a precisely controlled stirring device. At the same time, the intelligent ultrasonic equipment automatically optimizes the ultrasonic processing parameters according to the characteristics of different viruses. The virus type is set as a specific variable, combined with its characteristic parameter set, such as virus particle size, hardness, structural stability, etc., and the ultrasonic frequency and processing time are determined by using the functional relationship fitted by experimental data and machine learning algorithms. This can fully release the virus particles while avoiding damage to the antibody structure. Then comes the antibody capture step, which uses an antibody capture reagent based on nano-antibody capture technology, consisting of ultra-fine nano-magnetic beads and The nano-antibodies modified by special processes are composed of pre-treated samples and antibody capture reagents in an intelligent temperature-controlled incubation device. Within a specific temperature and time range, the virus antibodies in the sample are ensured to be efficiently combined with the nano-antibodies on the magnetic beads. The strictly screened and optimized nano-antibodies have extremely high specificity and affinity for the antigens of different viruses, covering the key areas of surface proteins and internal proteins of gynecological infectious disease viruses. After that, a new generation of multifunctional detection instruments are used for detection and analysis. The instrument integrates a variety of advanced detection technologies and has an intelligent algorithm that can automatically adjust the detection parameters according to different viruses. During the detection process, the instrument quickly analyzes the signals emitted by the magnetic beads combined with virus antibodies and accurately determines the content of virus antibodies in the sample. At the same time, multiple encryption and security authentication mechanisms are used during data transmission and storage to ensure the integrity and security of the detection data. Finally, based on the results given by the detection instrument, combined with the precise judgment criteria set based on big data analysis and artificial intelligence algorithms, it is determined whether the patient is infected with gynecological infectious disease viruses. Personalized and dynamically adjusted judgment criteria are set for different viruses to further improve the accuracy of the test results. The entire operation process is efficient, accurate and safe, providing strong technical support for the prevention and treatment of gynecological infectious diseases.
[0036] The electronic components and modules used in the invention can be parts commonly used in the market and can realize the specific functions in this case, and the specific models and sizes can be selected and adjusted according to actual needs.
[0037] The above shows and describes the basic principles, main features and advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention to be protected. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A method for detecting antibodies against gynecological infectious diseases, characterized in that: The following steps are involved: Step 1: Use an intelligent sterile gynecological sample collection system to collect cervical secretions, vaginal secretions, or selectively collect urine, blood and other auxiliary samples according to specific circumstances. The collection process is equipped with a real-time monitoring device to ensure aseptic operation standards, and detect common gynecological infectious viruses such as human papillomavirus (HPV), herpes simplex virus (HSV), and molluscum virus MCV; Step 2: Place the collected sample in a multifunctional buffer composed of an efficient phosphate buffer, a new environmentally friendly surfactant and a strong stabilizer, gently stir it with a precisely controlled stirring device, and use an intelligent ultrasonic device for ultrasonic treatment. Suppose the virus type is V, and the virus characteristic parameter set is C(V) = {c1, c2, ..., c n }, where c i Represents different virus characteristic parameters, such as virus particle size, hardness, structural stability, etc. The ultrasonic frequency is f=F(C(V)), and the processing time is t=T(C(V)), where F and T are functional relationships fitted by experimental data and machine learning algorithms. The ultrasonic processing parameters can be automatically optimized according to different virus characteristics. During the operation of the algorithm, the Advanced Encryption Standard (AES) is used to encrypt the virus characteristic parameters and the calculation process. The Secure Sockets Layer (SSL) protocol is used during data transmission and storage to ensure data security and confidentiality and prevent unauthorized access and tampering. At the same time, strict access control is set, and only authorized personnel can access algorithm-related data and operation processes; Step 3: Use the antibody capture reagent based on nano-antibody capture technology, which is composed of ultra-fine nano-magnetic beads and specially engineered nano-antibodies. Mix the pre-treated sample with the antibody capture reagent in an intelligent temperature-controlled incubation device. The incubation temperature range is 36-44°C and the time is 32-58 minutes to ensure that the viral antibodies in the sample are efficiently combined with the nano-antibodies on the magnetic beads. For different viruses, the nano-antibodies have been strictly screened and optimized, and have extremely high specificity and affinity for viral antigens, covering the key areas of surface proteins and internal proteins of gynecological infectious disease viruses; Step 4: Use a new generation of multifunctional detection instruments, which integrate multiple detection technologies such as fluorescent immunoassay, enzyme-linked immunosorbent assay, chemiluminescent immunoassay and quantum dot immunoassay. It has an intelligent algorithm that can automatically adjust the detection parameters according to different viruses. The built-in quality monitoring system monitors the instrument performance and the reliability of the test results in real time. It has a strong data processing capability to quickly analyze the test signal and accurately determine the virus antibody content in the sample. It also supports remote control and data transmission functions. In the process of data transmission and storage, multiple encryption technologies are used, including a combination of symmetric encryption and asymmetric encryption, to encrypt the test data, and digital certificates are used for identity authentication to ensure that the identities of both parties in the data transmission are authentic and reliable. In addition, the software system of the detection instrument is regularly updated and scanned for vulnerabilities to prevent potential security risks; Step 5: Based on the results of the detection instrument, combined with the precise judgment criteria set based on big data analysis and artificial intelligence algorithms, determine whether the patient is infected with gynecological infectious viruses, and set personalized and dynamically adjusted judgment criteria for different viruses.
2. A method for detecting antibodies to gynecological infectious diseases according to claim 1, characterized in that: The concentration of the phosphate buffer in the multifunctional buffer can be adjusted within the range of 0.02-0.09 mol / L, the concentration of the new environmentally friendly surfactant is 0.02%-0.09%, and the concentration of the strong stabilizer is 0.2%-0.9%. For different viruses, the specific composition and concentration of the buffer can be automatically adjusted by the intelligent system.
3. A method for detecting antibodies to gynecological infectious diseases according to claim 2, characterized in that: The nanoantibodies in the antibody capture reagent are specially engineered single-domain antibodies that target viral antigens covering key regions of surface proteins and internal proteins of gynecological infectious virus. They have high specificity and affinity for different viruses and are screened by an intelligent screening system.
4. A method for detecting antibodies to gynecological infectious diseases according to claim 3, characterized in that: The incubation conditions of the intelligent temperature-controlled incubation device can be automatically set and optimized according to different viruses.
5. A method for detecting antibodies to gynecological infectious diseases according to claim 4, characterized in that: The new generation of multifunctional detection instrument has ultra-high sensitivity, specificity and rapid detection capabilities. It can automatically select and adjust detection methods and parameters according to different viruses, realize remote control and data transmission, and facilitate medical institutions to conduct remote consultation and quality control. At the same time, the instrument strictly abides by information security specifications during operation to ensure the security and privacy protection of detection data.
